Intravenous Indocyanine Green for Localization of Intra-thoracic Lesions

Completed · Phase 1/Phase 2

Conditions studied: Pulmonary Nodule, Solitary, Pulmonary Nodule, Multiple

In brief

This is a clinical trial to evaluate the intravenous administration of indocyanine green (ICG) as a method of intra-thoracic lesion localization. The primary purpose is to determine if intravenous ICG allows us to identify intra-thoracic lesions.

Key facts

Study ID

NCT03097627

Run by

Brigham and Women's Hospital

People needed

4

Starts

2016-02-01

Expected to finish

2016-10-28

Last updated by the study team

2017-12-12

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients with intra-thoracic lesions that require resection for therapeutic or diagnostic purposes as recommended by their thoracic surgeon.
• 18 years of age or older
• Documented, signed, dated informed consent obtained prior to any study specific procedures being performed

You may not qualify if…

• Subjects who do not wish to have subsequent surgical resection
• A medical condition such as uncontrolled infection or cardiac disease that, in the opinion of the treating surgeon, makes resection unreasonably hazardous for the patient
• Pre-operative spirometry that suggests the patient is at high risk or cannot undergo resection of the primary tumor.
• Iodide or seafood allergy

Where it is running

• Brigham and Women's Hospital — Boston, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.